151 related articles for article (PubMed ID: 34499741)
21. Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients.
Bingmer KE; Hue JJ; Sugumar K; Ammori JB; Rothermel LD; Winter JM; Hardacre JM; Ocuin LM
HPB (Oxford); 2022 Feb; 24(2):217-225. PubMed ID: 34247942
[TBL] [Abstract][Full Text] [Related]
22. Treatment Inequity: Examining the Influence of Non-Hispanic Black Race and Ethnicity on Pancreatic Cancer Care and Survival in Wisconsin.
Schiefelbein AM; Krebsbach JK; Taylor AK; Zhang J; Haimson CE; Trentham-Dietz A; Skala MC; Eason JM; Weber SM; Varley PR; Zafar SN; LoConte NK
WMJ; 2022 Jul; 121(2):77-93. PubMed ID: 35857681
[TBL] [Abstract][Full Text] [Related]
23. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.
Mpilla GB; Philip PA; El-Rayes B; Azmi AS
World J Gastroenterol; 2020 Jul; 26(28):4036-4054. PubMed ID: 32821069
[TBL] [Abstract][Full Text] [Related]
25. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
[TBL] [Abstract][Full Text] [Related]
26. Healthcare disparities in outcomes of patients with resectable pancreatic cancer.
Moaven O; Richman JS; Reddy S; Wang T; Heslin MJ; Contreras CM
Am J Surg; 2019 Apr; 217(4):725-731. PubMed ID: 30583797
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Neuroendocrine Tumors and Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review.
Manuel-Vazquez A; Ramia JM; Latorre-Fragua R; Valle-Rubio A; Arteaga-Peralta V; Ramiro-Pérez C; de la Plaza-Llamas R
Pancreas; 2018; 47(5):551-555. PubMed ID: 29683974
[TBL] [Abstract][Full Text] [Related]
28. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis.
Mei W; Cao F; Lu J; Qu C; Fang Z; Li J; Li F
Front Endocrinol (Lausanne); 2023; 14():1140873. PubMed ID: 37020595
[TBL] [Abstract][Full Text] [Related]
30. Racial and ethnic disparities in survival of children with brain and central nervous tumors in the United States.
Haizel-Cobbina J; Spector LG; Moertel C; Parsons HM
Pediatr Blood Cancer; 2021 Jan; 68(1):e28738. PubMed ID: 32970937
[TBL] [Abstract][Full Text] [Related]
31. Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally.
Lutfi W; Zenati MS; Zureikat AH; Zeh HJ; Hogg ME
Ann Surg Oncol; 2018 Jul; 25(7):1860-1867. PubMed ID: 29691733
[TBL] [Abstract][Full Text] [Related]
32. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
33. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
[TBL] [Abstract][Full Text] [Related]
34. Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence.
Power DG; Shia J; Allen PJ; Jarnagin WR; O'Reilly EM
Clin Colorectal Cancer; 2011 Jun; 10(2):146-50. PubMed ID: 21859569
[TBL] [Abstract][Full Text] [Related]
35. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
Chen J; Yang Y; Liu Y; Kan H
World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
[TBL] [Abstract][Full Text] [Related]
36. Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.
Nießen A; Schimmack S; Weber TF; Mayer P; Bergmann F; Hinz U; Büchler MW; Strobel O
Pancreatology; 2021 Jan; 21(1):224-235. PubMed ID: 33309225
[TBL] [Abstract][Full Text] [Related]
37. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
38. The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer.
Mitsakos AT; Irish W; Parikh AA; Snyder RA
PLoS One; 2022; 17(2):e0263818. PubMed ID: 35176030
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
Halfdanarson TR; Rabe KG; Rubin J; Petersen GM
Ann Oncol; 2008 Oct; 19(10):1727-33. PubMed ID: 18515795
[TBL] [Abstract][Full Text] [Related]
40. County-Level Factors Associated With Cardiovascular Mortality by Race/Ethnicity.
Zuma BZ; Parizo JT; Valencia A; Spencer-Bonilla G; Blum MR; Scheinker D; Rodriguez F
J Am Heart Assoc; 2021 Mar; 10(6):e018835. PubMed ID: 33653083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]